Literature DB >> 27401890

Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement.

Eduard Vrdoljak1, Gyorgy Bodoky2, Jacek Jassem3, Razvan A Popescu4, Jozef Mardiak5, Robert Pirker6, Tanja Čufer7, Semir Bešlija8, Alexandru Eniu9, Vladimir Todorović10, Kateřina Kubáčková11, Galia Kurteva12, Zorica Tomašević13, Agim Sallaku14, Snezhana Smichkoska15, Žarko Bajić16, Branimir I Šikić17.   

Abstract

: The incidence of many cancers is higher in Western European (WE) countries, but mortality is frequently higher in Central and Eastern European (CEE) countries. A panel of oncology leaders from CEE countries participating in the South Eastern European Research Oncology Group (SEEROG) was formed in 2015, aiming to analyze the current status and trends of oncology care in CEE and to propose recommendations leading to improved care and outcomes. The SEEROG panel, meeting during the 11th Central European Oncology Congress, proposed the following: (a) national cancer control plans (NCCPs) required in all CEE countries, defining priorities in cancer care, including finance allocation considering limited health care budgets; (b) national cancer registries, describing in detail epidemiological trends; (c) efforts to strengthen comprehensive cancer centers; (d) that multidisciplinary care should be mandated by the NCCPs; (e) that smaller hospitals should be connected to multidisciplinary tumor boards via the Internet, providing access to specialized expertise; (f) nationwide primary prevention programs targeting smoking, obesity, and alcohol consumption and centrally evaluated secondary prevention programs for cervical, colorectal, and breast cancers; (g) prioritize education for all involved in cancer care, including oncology nurses, general practitioners, and palliative care providers; (h) establish outpatient care in day hospitals to reduce costs associated with the current inpatient model of care in CEE countries and to improve patients' quality of life; (i) long-term pharmacoeconomic evaluations of new therapies in CEE countries; (j) increase national oncology budgets in view of the higher mortality rates in CEE compared with WE countries; and (k) CEE countries urgently need help from the European Union to increase and monitor overall investment in cancer care. IMPLICATIONS FOR PRACTICE: Significant differences in cancer incidence and mortality have been observed between European countries. While the incidence of many cancer types is higher in Western European (WE) countries, the mortality is generally higher in Central and Eastern Europe (CEE). The primary purpose of this review was to describe the current status and trends of oncology care in the CEE region, to raise awareness among physicians, regulators, and payers, and to propose the most needed changes in order to make the oncology care in CEE closer to the WE standards. ©AlphaMed Press.

Entities:  

Keywords:  Cancer; Health care budget; Incidence; Mortality; Oncology; South-East Europe

Mesh:

Year:  2016        PMID: 27401890      PMCID: PMC5061531          DOI: 10.1634/theoncologist.2016-0137

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  22 in total

Review 1.  Global patterns of cancer incidence and mortality rates and trends.

Authors:  Ahmedin Jemal; Melissa M Center; Carol DeSantis; Elizabeth M Ward
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-07-20       Impact factor: 4.254

2.  Radiotherapy equipment and departments in the European countries: final results from the ESTRO-HERO survey.

Authors:  Cai Grau; Noémie Defourny; Julian Malicki; Peter Dunscombe; Josep M Borras; Mary Coffey; Ben Slotman; Marta Bogusz; Chiara Gasparotto; Yolande Lievens; Arianit Kokobobo; Felix Sedlmayer; Elena Slobina; Karen Feyen; Tatiana Hadjieva; Karel Odrazka; Jesper Grau Eriksen; Jana Jaal; Ritva Bly; Bruno Chauvet; Normann Willich; Csaba Polgar; Jakob Johannsson; Moya Cunningham; Stefano Magrini; Vydmantas Atkocius; Michel Untereiner; Martin Pirotta; Vanja Karadjinovic; Sverre Levernes; Krystol Sladowski; Maria Lurdes Trigo; Barbara Šegedin; Aurora Rodriguez; Magnus Lagerlund; Bert Pastoors; Peter Hoskin; Jaap Vaarkamp; Ramon Cleries Soler
Journal:  Radiother Oncol       Date:  2014-10-31       Impact factor: 6.280

3.  American Society of Clinical Oncology position statement on obesity and cancer.

Authors:  Jennifer A Ligibel; Catherine M Alfano; Kerry S Courneya; Wendy Demark-Wahnefried; Robert A Burger; Rowan T Chlebowski; Carol J Fabian; Ayca Gucalp; Dawn L Hershman; Melissa M Hudson; Lee W Jones; Madhuri Kakarala; Kirsten K Ness; Janette K Merrill; Dana S Wollins; Clifford A Hudis
Journal:  J Clin Oncol       Date:  2014-10-01       Impact factor: 44.544

4.  Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study.

Authors:  Roberta De Angelis; Milena Sant; Michel P Coleman; Silvia Francisci; Paolo Baili; Daniela Pierannunzio; Annalisa Trama; Otto Visser; Hermann Brenner; Eva Ardanaz; Magdalena Bielska-Lasota; Gerda Engholm; Alice Nennecke; Sabine Siesling; Franco Berrino; Riccardo Capocaccia
Journal:  Lancet Oncol       Date:  2013-12-05       Impact factor: 41.316

Review 5.  Applying what we know to accelerate cancer prevention.

Authors:  Graham A Colditz; Kathleen Y Wolin; Sarah Gehlert
Journal:  Sci Transl Med       Date:  2012-03-28       Impact factor: 17.956

6.  Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000.

Authors:  Stella Chang; Stacey R Long; Lucie Kutikova; Lee Bowman; Denise Finley; William H Crown; Charles L Bennett
Journal:  J Clin Oncol       Date:  2004-09-01       Impact factor: 44.544

7.  Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.

Authors:  Henrike E Karim-Kos; Esther de Vries; Isabelle Soerjomataram; Valery Lemmens; Sabine Siesling; Jan Willem W Coebergh
Journal:  Eur J Cancer       Date:  2008-02-14       Impact factor: 9.162

8.  Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012.

Authors:  J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray
Journal:  Eur J Cancer       Date:  2013-02-26       Impact factor: 9.162

9.  Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980.

Authors:  C Bosetti; P Bertuccio; M Malvezzi; F Levi; L Chatenoud; E Negri; C La Vecchia
Journal:  Ann Oncol       Date:  2013-08-06       Impact factor: 32.976

10.  Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis.

Authors:  V Bagnardi; M Rota; E Botteri; I Tramacere; F Islami; V Fedirko; L Scotti; M Jenab; F Turati; E Pasquali; C Pelucchi; C Galeone; R Bellocco; E Negri; G Corrao; P Boffetta; C La Vecchia
Journal:  Br J Cancer       Date:  2014-11-25       Impact factor: 7.640

View more
  16 in total

1.  [Substantial advantage of CT-planned HDR brachytherapy for cervical cancer patients compared to a historical series with regard to local control and toxicity?]

Authors:  Simone Marnitz
Journal:  Strahlenther Onkol       Date:  2017-03       Impact factor: 3.621

2.  Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe.

Authors:  Eduard Vrdoljak; Gyorgy Bodoky; Jacek Jassem; Razvan Popescu; Robert Pirker; Tanja Čufer; Semir Bešlija; Alexandru Eniu; Vladimir Todorović; Katerina Kopečková; Galia Kurteva; Zorica Tomašević; Agim Sallaku; Snezhana Smichkoska; Žarko Bajić; Branimir Sikic
Journal:  Oncologist       Date:  2018-09-04

3.  Telemedicine in Neurological Disorders: Opportunities and Challenges.

Authors:  Martina Chirra; Luca Marsili; Linsdey Wattley; Leonard L Sokol; Elizabeth Keeling; Simona Maule; Gabriele Sobrero; Carlo Alberto Artusi; Alberto Romagnolo; Maurizio Zibetti; Leonardo Lopiano; Alberto J Espay; Ahmed Z Obeidat; Aristide Merola
Journal:  Telemed J E Health       Date:  2018-08-23       Impact factor: 3.536

4.  Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.

Authors:  Tanja Cufer; Tudor E Ciuleanu; Peter Berzinec; Gabriela Galffy; Marko Jakopovic; Jacek Jassem; Dragana Jovanovic; Zhasmina Mihaylova; Gyula Ostoros; Christiane Thallinger; Milada Zemanova; Christoph Zielinski
Journal:  Oncologist       Date:  2019-11-29

5.  Net survival of patients with colorectal cancer: a comparison of two periods.

Authors:  Zdravko Štor; Rok Blagus; Alessandro Tropea; Antonio Biondi
Journal:  Updates Surg       Date:  2019-06-12

6.  Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.

Authors:  Ales Ryska; Rares Buiga; Albena Fakirova; Izidor Kern; Włodzimierz Olszewski; Lukas Plank; Sven Seiwerth; Erika Toth; Eri Zivka; Christiane Thallinger; Christoph Zielinski; Luka Brcic
Journal:  Oncologist       Date:  2018-08-03

7.  Advancing Breast Cancer Advocacy in Eastern Europe and Central Asia: Findings From Women's Empowerment Cancer Advocacy Network (WE CAN) Summits.

Authors:  Nicoleta Antone; Darya Kizub; Julie Gralow; Jo Anne Zujewski; Allison Dvaladze
Journal:  JCO Glob Oncol       Date:  2021-04

8.  Cancer Control in Central and Eastern Europe.

Authors:  Carlo La Vecchia; Pierfranco Conte
Journal:  Oncologist       Date:  2016-07-08

9.  Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center.

Authors:  Marija Ivanović; Lea Knez; Ana Herzog; Mile Kovačević; Tanja Cufer
Journal:  Oncologist       Date:  2021-08-02

10.  Cancer mortality in Serbia, 1991-2015: an age-period-cohort and joinpoint regression analysis.

Authors:  Milena Ilic; Irena Ilic
Journal:  Cancer Commun (Lond)       Date:  2018-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.